GCM
OLMA icon

Graham Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Graham Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$249K Buy
+16,710
New +$372K 0.01% 884
2025
Q2 		– Sell
-46,510
Closed -$175K – 1528
2025
Q1 		$175K Buy
+46,510
New +$234K ﹤0.01% 1156

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Graham Capital Management's OLMA Position: Q1 2026 in Review

Graham Capital Management opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 16,710 shares worth $249K. The stake represents 0.01% of the portfolio and ranks #884 among its holdings. This is a return to the name: Graham Capital Management previously reported a position in OLMA as recently as Q1 2025.

Graham Capital Management first reported a position in OLMA in Q1 2025 and has held it in 2 quarters since. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Graham Capital Management held 16,710 shares of Olema Pharmaceuticals worth $249K as of Q1 2026.
  • Olema Pharmaceuticals was a new Graham Capital Management position in Q1 2026.
  • Olema Pharmaceuticals made up 0.01% of Graham Capital Management's portfolio in Q1 2026, its #884 holding.
  • Graham Capital Management first reported a position in Olema Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.